As part of a medical education initiative in China, CWC has established the China Academy of Controversies, Debates & Consensus in Medicine. The Academy is honored to be chaired by Prof. Zeyi Cao, former Deputy Minister of Health of the P.R. China. The Academy promotes medical education, research and clinical development in China, through the organization of specialized Forum meetings and e-learning tools creating a new and unique source of...
CWC Strategy
China has become a key contributor to absolute value growth in global revenues of the healthcare industry. CWC advises pharmaceutical and medical device companies on market entry strategies and broadening of market share, sourcing of manufacturing facilities and distribution platforms, support of SFDA approvals and regulatory issues, as well as facilitation of clinical trials in China. CWC has developed a broad understanding of the health care sector in China and...
Access to China
CWC Tech
It is estimated that by 2020, Asia-Pacific will be the second largest market for healthcare technology. CWC offers med-tech companies aspiring to enter that Chinese market comprehensive solutions, from access strategies, expert opinion, fulfilling regulatory obligations, obtaining SFDA approvals, providing local manufacturing capabilities, creating nations-wide distribution networks, as well as governmental and private investment opportunities. Read more about CWC Tech...
CWC Invest
In the past 20 years, China has begun...